Founded in 1999 by professionals of the animal health, LOBS International Health aims to develop and make available a range of veterinary medicines adapted to the needs of the markets in which LOBS operates.

Ivermec (injectable ivermectin) is launched in Mali in 1999, this first product is quickly joined by a range of 10 products that are distributed in the West African, Maghreb and East African areas.

Veterinarians and users quickly associate LOBS products to 3 ideas: Efficiency, innovation, competitiveness.

In 2004, LOBS invested in a new production site and set up a highly qualified team. Quality Control is implemented at each stage of the production and distribution of products; At the same time, LOBS is continuing to develop its range.

LOBS also has partnerships in India and China to ensure the quality and consistency of its raw material supplies, one of the keys to consistent quality.

In 2008, LOBS is growing rapidly with a significant presence in more than 15 countries. Its investments mainly concern a range of trypanocides that now include 3 active ingredients: Diminazene aceturate (LOBAZEN / FORTEZEN), Isometamidium (LOBIDIUM) and Homidium Chloride (ACTIDIUM).

LOBS now has a range of 65 products and is located in 25 countries in Africa, the Middle East and Eastern Europe with many marketing authorizations.

In 2016, LOBS launches its 15th national vaccination campaign in Angola and reaches its 10th year of consecutive growth.

LOBS counts in 2018 a range of 65 products and is implanted in 25 countries located in Africa, Middle East and Eastern Europe with many AMM.

In every investment and deployment, our team refers to its motto “LOBS, a requirement for efficiency and innovation”.